Lovisa returns to pre-COVID levels on European acquisition
Por um escritor misterioso
Descrição
On the back of a European acquisition, Jewellery retailer Lovisa (ASX: LOV) has seen its shares bounce back to levels not seen since the COVID-19 pandemic slamm
Development of New Leishmanicidal Compounds via Bioconjugation of
Cerebral hypoperfusion in post-COVID-19 cognitively impaired
Frontiers Enzyme linked oligonucleotide assay for the sensitive
N-CSR
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Poster abstracts, 2023
Economic Bulletin Issue 2, 2021
Biomedicines, Free Full-Text
Eurasia Rising: COVID-19 in Latin America > National Defense
Class switch toward noninflammatory, spike-specific IgG4
N-CSR
ACP - Relations - Measurement report: The 4-year variability and
Harnessing Nanovaccines for Effective Immunization─A Special
Patients' and professionals' perspective of non-in-person visits
de
por adulto (o preço varia de acordo com o tamanho do grupo)